_pep-guardiola-issues-manchester-city-warning-after-fulham-players-filmed-flying-kites-in-training.jpg "Pep Guardiola issues Manchester City warning after Fulham players filmed flying kites in training from rival Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 0:57
👁 View: 9.1M times
✓ Published: 11-May-2024
👁 View: 9.1M times
✓ Published: 11-May-2024
Description:
Pep Guardiola has no doubt Fulham will “do everything” to beat Manchester City on Saturday no matter how much fun they have had in training.Video footage circulated this week of some of Fulham’s squad flying kites at the club’s training ground during a lighter moment in their schedule.That prompted some fans of City’s title rivals Arsenal to question whether the mid-table Cottagers will have their minds fully on the job as they prepare to host the champions on Saturday.SOURCE: PA
Pep Guardiola has no doubt Fulham will “do everything” to beat Manchester City on Saturday no matter how much fun they have had in training.Video footage circulated this week of some of Fulham’s squad flying kites at the club’s training ground during a lighter moment in their schedule.That prompted some fans of City’s title rivals Arsenal to question whether the mid-table Cottagers will have their minds fully on the job as they prepare to host the champions on Saturday.SOURCE: PA
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_meghan-and-harry-are-desperately-trying-to-be-rival-royal-family-to-save-image-us-tours-are-next.webp "The Sun")
⏲ 9 minutes 5 seconds 👁 17.4K
_postecoglou-rubbishes-suggestion-spurs-will-roll-out-red-carpet-for-man-city-basic-premise.webp "Ange Postecoglou is adamant that Tottenham will not be rolling out a red carpet for Manchester City as they face them at home on Tuesdsay.Spurs host Premier League champions City in a match that may leave the home supporters with mixed emotions given a positive result against Pep Guardiola’s men would put arch-rivals Arsenal in the driving seat to win the title.The Gunners currently hold a two-point advantage at the summit, but have played a game more than City, who could return to top spot with victory in north London.")
⏲ 1:24 👁 14.6M
_garten-of-banban-3-song-9234rivals9234-official-car-song.webp "Rockit Music")
_romeo-santos-ft-mario-domm-rival-letras-lyrics-official-music-2011.webp "Francheska Martinez")
⏲ 4 minutes 13 seconds 👁 6.1M
_garten-of-banban-3-official-car-song-9234rivals9234-cartoon-animation.webp "Rockit Music")
_rival-x-blanke-heaven-w-kc-official-visualizer.webp "Rival")
_new-analysis-suggests-long-term-effectiveness-for-wegovy-users.webp "New Analysis Suggests , Long-Term Effectiveness , for Wegovy Users .<br/>NBC reports that patients taking <br/>Novo Nordisk's obesity treatment maintain <br/>an average of 10% weight loss over four years.<br/>The news potentially boosts the <br/>drugmaker's push for Wegovy to be <br/>covered by insurers and governments. .<br/>The company submitted long-term <br/>findings at the European Congress <br/>on Obesity in Venice, Italy. .<br/>This is the longest study <br/>we’ve conducted so far of <br/>semaglutide for weight loss, Martin Holst Lange, Novo’s head of development, via NBC.<br/>We see that once the majority <br/>of the weight loss is accrued, <br/>you don’t go back and start <br/>to increase in weight<br/>if you stay on the drug, Martin Holst Lange, Novo’s head of development, via NBC.<br/>According to another analysis published by <br/>the drugmaker, approximately 17% of trial participants stopped using the treatment <br/>due to side effects like nausea. .<br/>The costly treatment ranges from $200 <br/>to nearly $2,000 per month in the ten <br/>countries where the drug is available.<br/>NBC reports that Novo Nordisk was the <br/>first drugmaker to market GLP-1 agonists, <br/>originally developed as a diabetes treatment, <br/>to address record high obesity rates.<br/>NBC reports that Novo Nordisk was the <br/>first drugmaker to market GLP-1 agonists, <br/>originally developed as a diabetes treatment, <br/>to address record high obesity rates.<br/>Rival Eli Lilly launched its drug <br/>Zepbound in the United States <br/>in December of 2023. .<br/>Neither drugmaker has managed <br/>to produce enough of the <br/>treatment to meet surging demand")
_rival-x-lost-sky-where-you-are-w-jex-acoustic-version.webp "Rival")
_meghan-and-harry-are-desperately-trying-to-be-rival-royal-family-to-save-image-us-tours-are-next.jpg)
_postecoglou-rubbishes-suggestion-spurs-will-roll-out-red-carpet-for-man-city-basic-premise.jpg)
_garten-of-banban-3-song-9234rivals9234-official-car-song.jpg)
_romeo-santos-ft-mario-domm-rival-letras-lyrics-official-music-2011.jpg)
_garten-of-banban-3-official-car-song-9234rivals9234-cartoon-animation.jpg)
_rival-x-blanke-heaven-w-kc-official-visualizer.jpg)
_new-analysis-suggests-long-term-effectiveness-for-wegovy-users.jpg)
_rival-x-lost-sky-where-you-are-w-jex-acoustic-version.jpg)
![[+]](/images/menu.gif){kind=small}